ExploreWatchlistsPricing
  1. JP-listed companies
  2. SATO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Gross profit

SATO PHARMACEUTICAL CO.,LTD. (E00954)

Market cap
P/E ratio
Sato Pharmaceutical develops and sells over-the-counter medicines, prescription drugs, and health products to consumers and medical institutions globally.
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndGross profit (Million JPY)YoY (%)
Jul 31, 202327,400+8.40%
Jul 31, 202225,277+0.90%
Jul 31, 202125,051-7.85%
Jul 31, 202027,186-2.43%
Jul 31, 201927,864+10.19%
Jul 31, 201825,287+3.53%
Jul 31, 201724,424-0.59%
Jul 31, 201624,570-1.31%
Jul 31, 201524,895-1.58%
Jul 31, 201425,294

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat